Institute of Pathology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Immunoglobulin G4 (IgG4)-related disease of the stomach – a challenging differential diagnosis in suspected gastric cancer (2019) Probst A, Schaller T, Sommer F, Geissler B, Agaimy A, Messmann H, Märkl B Journal article IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. (2019) Langer V, Vivi E, Regensburger D, Winkler T, Waldner M, Rath T, Schmid B, et al. Journal article Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019) Weyerer V, Weisser R, Moskalev E, Haller F, Stöhr R, Eckstein M, Zinnall U, et al. Journal article miR-27a/b is a posttranscriptional regulator of Gpr126 (Adgrg6) (2019) Musa G, Srivastava S, Petzold J, Cazorla-Vazquez S, Engel F Journal article Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review (2019) Sarnak MJ, Amann KU, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, et al. Journal article, Review article Prevalence of an association between coeliac disease and vitiligo (2019) Henker J, Hartmann A Journal article Un- and dedifferentiated endometrial carcinoma A rare entity with a wide range of differential diagnosis (2019) Hoehn AK, Brambs CE, Opitz S, Erber R, Hartmann A, Horn LC Journal article A toolbox for functional analysis and the systematic identification of diagnostic and prognostic gene expression signatures combining meta-analysis and machine learning (2019) Vey J, Kapsner L, Fuchs M, Unberath P, Veronesi G, Kunz M Journal article Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial) (2019) Hecht M, Gostian AO, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Hautmann MG, et al. Conference contribution Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial (2019) Jarczyk J, Wirtz R, Roghmann F, Juette H, Kriegmair MC, Worst TS, Sikic D, et al. Conference contribution